Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we are enclosing herewith certificate issued by Registrar and Share Transfer Agents of the Company for Quarter ended December 31st 2024.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jan 06 2025
- Board Meeting Intimation for Increase In Authorised Capital And Fund Raising Proposal.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Dec 31 2024
- Closure of Trading Window
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Dec 27 2024
Later from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jan 13 2025
- We Would Like To Inform You That The Extra-Ordinary General Meeting Is Schedule To Be Held On Thursday, February 06, 2025, At 12: 00 PM Through Video Conferencing Or Other Audio Visual Means ("OAVM").
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jan 14 2025
- Board Meeting Intimation for Un-Audited Financial Results For The Quarter Ended 31St December 2024.
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals